scorecardresearchWealth destroyers! These stocks lost over 50% of their investor wealth

Wealth destroyers! These stocks lost over 50% of their investor wealth in just the last 1 year

Updated: 16 Feb 2022, 03:46 PM IST
TL;DR.

Five stocks of the NSE500 index have tanked over 50 percent in the last 1 year as against a 13 percent rise in the Nifty in this period. Three of those 5 stocks were pharma firms.

Five stocks of the NSE500 index have tanked over 50 percent in the last 1 year as against a 13 percent rise in the Nifty in this period. Three of those 5 stocks were pharma firms.

Five stocks of the NSE500 index have tanked over 50 percent in the last 1 year as against a 13 percent rise in the Nifty in this period. Three of those 5 stocks were pharma firms.

While the last 1 year has been a decent year for the Indian markets, some stocks have more than halved their investor returns in this period.

5 stocks of the NSE500 index have tanked over 50 percent in the last 1 year as against a 13 percent rise in the Nifty in this period. Three of those 5 stocks were pharma firms. The 5 stocks include Dhani Services, Strides Pharma, Solara Active, Ujjivan Financial Services and Bliss GVS Pharma.

Meanwhile, 15 stocks from NSE500 shed over 30 percent each and over 80 stocks fell in double-digits in the last 1 year.

Dhani Services has lost 63 percent in the last 1 year on the back of weak financial results. Incorporated in 1995, Dhani Services is a midcap company in the NBFC sector. In the December quarter, the company's net loss increased to 5.6 crore as against 4.9 crore in September quarter. Its revenue also fell to 10 crore in Q3FY22 from 11.4 crore in Q2FY22. For FY21, the firm reported a net loss of 16.7 crore and revenue of 30 crore.

Strides Pharma Sciences was the second-worst performer in the NSE500 index in the last 1 year, down 60 percent. The major reason for the sharp decline in Strides Pharma was weak September quarter numbers. The profitability was impacted by price erosion in one of its base products in the US markets as well as a surge in logistic costs.

In Q2, the company reported a consolidated net loss of 162.55 crore in Q2FY22 as against a net profit of 80.94 crore in Q2FY21. Revenue from operations during the quarter fell by 9.08 percent YoY to 721.47 crore. The logistics costs jumped 135 percent YoY.

Solara Active also lost nearly 60 percent in the last 1 year. The firm manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India. The company posted a loss of 139 crore in the December quarter. However, for FY21, its net profit stood at 221 crore and revenue at 1,617 crore.

Ujjivan Financial Services shed 52 percent in the last 1 year. The NBFC posted a narrowing of consolidated net loss to 181.56 crore for the quarter ended December 31, 2021. In the year-ago period, net loss was 490.73 crore. Total income during the third quarter stood at 732.47 crore, while total expenses were at 975.47 crore.

Lastly, Bliss GVS Pharma also declined 50 percent in the last 1 year. It is a smallcap firm that is engaged in developing, manufacturing and marketing pharmaceutical formulations.

Apart from these, Ujjivan Small Finance Bank, Dilip Buildcon, RBL Bank, IndiaMart, Spandana Sphoort, IOL Chemicals, Vakrangee, Future Retail, GE Power and CEAT also tanked over 35 percent each in the last 1 year.

 

Article
COVID Waves vs Stock Market Returns
First Published: 16 Feb 2022, 03:46 PM IST